State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Eli Lilly, the maker of the popular weight loss drug Zepbound, revealed what Bloomberg called a "shocking first miss" in its most recent quarterly sales announcement: in spite of bottomless hype ...

Viking says an early-stage study of its obesity pill VK2735 showed adults on the highest dosage lost 8.2% of their body ...

Should you forget Eli Lilly and buy this magnificent biotech instead? Let's find out.

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Eli Lilly, a pharmaceutical company, filed three separate lawsuits against online vendors and a medical spa for making knock off weight loss drugs. The pharmaceutical company's popular weight loss ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked in traditional channels. An injection pen of Zepbound, Eli Lilly’s ...

Apart from its pill, Viking is developing a weight loss injection and other treatments ... injectable treatments from Novo Nordisk and Eli Lilly. Patients with diabetes lost 5.8% of their ...